Carregant...
Breakthrough venous thromboembolic events in five patients with COVID‐19 on direct oral anticoagulants
WHAT IS KNOWN AND OBJECTIVE: Coronavirus disease 2019 (COVID‐19) is associated with increased risk of venous thromboembolism (VTE). Guidance for VTE prophylaxis continues to evolve, including addressing direct oral anticoagulants (DOACs) continued upon hospitalization. CASE SUMMARIES: We present 5 p...
Guardat en:
| Publicat a: | J Clin Pharm Ther |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7753371/ https://ncbi.nlm.nih.gov/pubmed/33217032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcpt.13311 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|